Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID-19 vaccine case report.

Published in: Clinical case reports (2023)

We describe a case of an otherwise healthy 60-year-old female patient who presented 6 days after receipt of the second dose of the BNT162b2 mRNA COVID-19 (Pfizer/BioNTech) vaccine and was found to have upper extremity deep venous thrombosis.

Keyphrases

case report
coronavirus disease
sars cov
binding protein